Carlos Murga-Zamalloa M.D.
University of Illinois at Chicago
H-index: 23
North America-United States
Top articles of Carlos Murga-Zamalloa M.D.
Title | Journal | Author(s) | Publication Date |
---|---|---|---|
Characterization of T-/natural killer cell lymphoproliferative neoplasms associated with systemic, chronic, active Epstein-Barr virus in adults: A report of 5 cases in a … | American Journal of Clinical Pathology | Carlos Murga-Zamalloa Michael Brandon Stone Marc G Gutierrez Neha Rajendra Hippalgaonkar Hamza Tariq | 2024/2/12 |
Recurrent fibrin-associated diffuse large B-cell lymphoma in a pediatric patient | Paige Reilly Carlos Murga-Zamalloa Husain Batool Huzaifa Alexander Javois Peter Varga | 2024/1/31 | |
Successful anti-tumor effects with two novel bifunctional chemotherapeutic compounds that combine a LAT1 substrate with cytotoxic moieties in aggressive T-cell lymphomas | Leukemia Research Reports | Carlos Murga-Zamalloa Shaun Webb John Reneau Alejandro Zevallos Pierina Danos-Diaz | 2024/1/1 |
Specific Polo-Like Kinase 1 Expression in Nodular Lymphocyte-Predominant Hodgkin Lymphoma Suggests an Intact Immune Surveillance Program | The American Journal of Pathology | Jonathan Weiss Kathryn Gibbons Vida Ehyaee Vanessa Perez-Silos Alejandro Zevallos | 2024/1/1 |
GATA-3–dependent Gene Transcription is Impaired upon HDAC Inhibition | Clinical Cancer Research | Xiangrong Geng Chenguang Wang Suhaib Abdelrahman Thilini Perera Badeia Saed | 2024/3/1 |
LYMPHOMA, MYELOMA LEUKEMIA | Jackson S Burton Nicole C Foley Neha Mehta-Shah Helen Ma Susan O’Brien | 2024/2 | |
GATA-3 Dependent Gene Transcription Is Impaired upon HDAC Inhibition | Blood | Xiangrong Geng Chenguang Wang Thilini Perera Badeia Saed Ying Hu | 2023/11/28 |
T-Cell Prolymphocytic Leukemia: Diagnosis, Pathogenesis, and Treatment | Marc Gutierrez Patrick Bladek Busra Goksu Carlos Murga-Zamalloa Dale Bixby | 2023/7/28 | |
Pre-Clinical Activity of Navitoclax in TCR-Driven and Non-ALCL Mature T-Cell Lymphomas | Blood | Xiangrong Geng Chenguang Wang Ashley Wolfe Ira Maine Suhaib Abdelrahman | 2023/11/28 |
Dynamin-2 deficiency causes age-and sex-dependent neutropenia and myelodysplasia in mice | Blood Advances | Alexander J Willis Seth J Corey Carlos Murga-Zamalloa Saman S Karimi Karam Khaddour | 2023/4/25 |
Xpo-1 Antagonism Impairs CSF-1R Expression and Depletes Lymphoma-Associated Macrophages in T-Cell Lymphomas | Blood | Nermin Kady Chenguang Wang Ashley Wolfe Ira Maine Suhaib Abdelrahman | 2023/11/28 |
SOHO state of the art updates and next questions| new pathways and new targets in PTCL: staying on target | Shannon A Carty Carlos A Murga-Zamalloa Ryan A Wilcox | 2023/4/19 | |
Xpo-1 Antagonism Transcriptionally Reprograms and Is a Therapeutic Vulnerability in GATA-3 Driven T-Cell Lymphomas | Blood | Chenguang Wang Nermin Kady Ashley Wolfe Ira Maine Suhaib Abdelrahman | 2023/11/28 |
Analytical and Clinical Significance of Rare Hemoglobin Variants during HbA1c Monitoring in Patients with Diabetes Mellitus: Two Cases of Hemoglobin G-Ferrara and Hemoglobin G … | The Journal of Applied Laboratory Medicine | Saman S Karimi Ming Jin Carlos Murga-Zamalloa | 2023/3/1 |
OR09-06 The Cholesterol Oxidation Product 7-Ketosterol Reduces Progesterone Production By Human Cytotrophoblast Cells In A Sex Dimorphic Manner | Journal of the Endocrine Society | Elvis Ticiani Natalia Pascuali Pierina Danos Carlos Murga-Zamalloa Irina Buhimschi | 2023/10 |
OPEN ACCESS EDITED BY | Community Series-Extremophiles: Microbial Genomics and Taxogenomics, Volume II | José Luis Losada Asier Gonzalez-Artetxe Yousri Elghoul Júlio A Costa JA Costa | 2023/11/22 |
Binding sites in the epidermal growth factor receptor are responsible for bisphenol S effects on trophoblast cell invasion | Chemosphere | Elvis Ticiani José A Villegas Carlos Murga-Zamalloa Almudena Veiga-Lopez | 2023/3/1 |
B-cell lymphoma-2 downregulation is a useful feature supporting a neoplastic phenotype in mature T-cell lymphomas | Human Pathology | Faiza Siddiqui Vanessa Perez Silos Kennosuke Karube Suleyman Yasin Goksu Srinath Nandakumar | 2022/7/1 |
Targeting lymphoma-associated macrophage expansion via CSF1R/JAK inhibition is a therapeutic vulnerability in peripheral T-cell lymphomas | Cancer Research Communications | Xin Gao Nermin Kady Chenguang Wang Suhaib Abdelrahman Peter Gann | 2022/12/30 |
CD30+ Primary intestinal T-cell lymphoma (unclassified) masquerading as chronic inflammation: a case report | Diagnostic Pathology | Kashif Osmani Eshana Shah Bradley Drumheller Shaun Webb Manmeet Singh | 2022/6/25 |